Gene testing to guide cancer treatment in children and young adults
Part of Cancer clinical trials.
This study looks at your genes to help doctors choose the safest and most effective cancer medicines for you. It is for children and young adults who are newly diagnosed and about to start treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 26 years old or younger.
- You must have just been diagnosed with cancer and be about to start treatment, or need a bone marrow transplant for a non-cancer condition.
- You must not have started anti-cancer therapy yet (except for spinal fluid chemo).
- You must not have had a bone marrow or organ transplant before.
- If you're planning a transplant as part of your first cancer treatment, you may not be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a treatment plan that uses results from genetic testing of your tumor to choose the best targeted therapy. It may help people whose cancer has come back or does not respond to standard treatment by matching treatment to specific tumor changes.
This study looks at whole genome sequencing (a complete read of your DNA) from children and young people with cancer. It aims to learn more about cancer and how it might be treated.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study tests a new way to offer genetic testing to young adults (ages 18-39) who have or had cancer. The goal is to make it easier for you to learn if you have inherited gene changes that could affect your cancer and your family's health.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.